Introduction:
FUJIFILM Diosynth Biotechnologies invests US$1.6 billion (11 billion Danish kroner)for the expansion in Hillerod, Denmark.
Features:
The expansion increases the capacity of the existing site by adding 8 x 20,000L bioreactors and two downstream processing streams.
The new site will adda total of 20 x 20,000L bioreactors for producing drug substance complemented by comprehensive drug product and finished goods services. Moreover, the addition of bioreactors will makeone of the largest CDMO site in Europe.
The expansion further strengthens cell culture manufacturing services. The project also provides measures to support new “Green Value Climate Strategy” by targeting carbon-free energy by bringing net zero CO2 emissions by the end of Fiscal Year 2040. In addition, it also provideswater conservation and renewable energy, among other green pushes.
The new project is expected to be fully opeartional in summer 2026 and create over 450 new jobs.
Specifications:
| Name | FUJIFILM Diosynth Biotechnologies |
| Type | New Construction |
| Budget | USD 1.6 billion (11 billion Danish kroner) |
